Are Gene Expression Profile Testing Scores Associated with New Onset Cardiac Allograft Vasculopathy?

Cardiac allograft vasculopathy (CAV) remains a leading cause of death after heart transplantation (HT). Its detection relies on coronary angiography and assessment of maximal intimal thickness (MIT) by intravascular ultrasound (IVUS). Gene Expression Profile (GEP) testing is a non-invasive way to survey rejection post-HT; however, whether it may help detect chronic rejection in the form of CAV is unknown.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: 223 Source Type: research